In obese PCOS patients, 6-month metformin treatment resulted in improved insulin sensitivity, menstrual regularity, and attenuated free testosterone and fasting insulin levels (Romualdi et al. 2011). This evidence concerns the gene INS and polycystic ovary syndrome.